In Brief: MiniMed/Boehringer Mannheim
This article was originally published in The Gray Sheet
Executive Summary
MiniMed/Boehringer Mannheim: Firms enter co-marketing agreement, effective June 1, under which the firms' sales and marketing forces will cooperate in promoting their diabetes care products in the U.S. The firms will create a joint sales and marketing "council" to develop "promotional materials and sales strategies" for U.S. operations, MiniMed says. The deal brings together Boehringer, the largest producer of glucose meters and test strips worldwide and the second largest producer of in vitro diagnostics, and MiniMed, which markets lines of external infusion systems for diabetes management in the U.S. and sells implantable infusion devices overseas. MiniMed also plans to commence multicenter clinical trials of a minimally-invasive subcutaneous glucose monitor in late 1996...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.